TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response.
暂无分享，去创建一个
E. Winer | L. Carey | J. Garber | H. Rugo | D. Finkelstein | P. Goss | L. Ellisen | V. Stearns | S. Isakoff | S. Come | P. Ryan | E. Mayer | K. Krag | D. Borger | M. Liu | T. Traina | C. A. Quadrino | M. C. Liu